-
Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-alphav integrin regulates cross-talk between alphavbeta3 and alpha2beta1 integrins in breast carcinoma cells.
Exp Cell Res. 2003 Nov 15;291(1):167-75
PMID: 14597417
-
The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression.
Anticancer Res. 2005 Jan-Feb;25(1A):79-83
PMID: 15816522
-
Adhesion and migration of extracellular matrix-stimulated breast cancer.
J Surg Res. 2003 Mar;110(1):287-94
PMID: 12697413
-
Integrin signaling.
Science. 1999 Aug 13;285(5430):1028-32
PMID: 10446041
-
Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone.
FASEB J. 2002 Aug;16(10):1266-8
PMID: 12153995
-
Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.
Int J Cancer. 2000 Apr 1;86(1):15-23
PMID: 10728589
-
Laminin 10/11: an alternative adhesive ligand for epidermal keratinocytes with a functional role in promoting proliferation and migration.
Exp Dermatol. 2002 Oct;11(5):387-97
PMID: 12366691
-
Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
Clin Cancer Res. 2005 Jan 1;11(1):306-14
PMID: 15671560
-
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
J Clin Invest. 1995 Oct;96(4):1815-22
PMID: 7560073
-
MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells.
Exp Cell Res. 2001 Feb 15;263(2):209-23
PMID: 11161720
-
Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins.
Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):763-8
PMID: 14718670
-
Prinomastat, a hydroxamate inhibitor of matrix metalloproteinases, has a complex effect on migration of breast carcinoma cells.
Int J Cancer. 2003 May 1;104(5):533-41
PMID: 12594807
-
Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
Mol Cancer Res. 2005 Jan;3(1):1-13
PMID: 15671244
-
Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases.
Clin Exp Metastasis. 2003;20(5):413-20
PMID: 14524530
-
Adhesion events in angiogenesis.
Curr Opin Cell Biol. 2001 Oct;13(5):563-8
PMID: 11544024
-
Development of skeletal metastases.
Clin Orthop Relat Res. 1995 Mar;(312):45-50
PMID: 7634617
-
Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas.
Int J Cancer. 1997 May 2;71(3):320-4
PMID: 9139861
-
Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
Mol Cancer Res. 2003 Sep;1(11):810-9
PMID: 14517343
-
The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells.
J Biol Chem. 1996 Feb 2;271(5):2443-7
PMID: 8576205
-
Platelet and osteoclast beta3 integrins are critical for bone metastasis.
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14205-10
PMID: 14612570
-
Integrin activation controls metastasis in human breast cancer.
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1853-8
PMID: 11172040
-
Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibody of c7E3 Fab (abciximab; ReoPro).
Angiogenesis. 1999;3(1):53-60
PMID: 14517444
-
Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
Nat Med. 2002 Jan;8(1):27-34
PMID: 11786903
-
Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
J Cell Physiol. 1998 Sep;176(3):482-94
PMID: 9699501
-
Mechanisms of osteolytic bone metastases in breast carcinoma.
Cancer. 2003 Feb 1;97(3 Suppl):834-9
PMID: 12548583
-
Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components.
Lab Invest. 1997 Dec;77(6):665-75
PMID: 9426405
-
The role of alpha(v)beta(3) in prostate cancer progression.
Neoplasia. 2002 May-Jun;4(3):191-4
PMID: 11988838
-
Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
Clin Cancer Res. 1998 Nov;4(11):2625-34
PMID: 9829725
-
Genes involved in breast cancer metastasis to bone.
Cell Mol Life Sci. 2002 Sep;59(9):1491-502
PMID: 12440771
-
Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase.
J Biol Chem. 2002 Mar 22;277(12):9749-56
PMID: 11724803
-
A novel orthotopic model of breast cancer metastasis to bone.
Clin Exp Metastasis. 1999 Mar;17(2):163-70
PMID: 10411109
-
Role of stromal-derived cytokines and growth factors in bone metastasis.
Cancer. 2003 Feb 1;97(3 Suppl):733-8
PMID: 12548570
-
Clinical course and prognostic factors following bone recurrence from breast cancer.
Br J Cancer. 1998;77(2):336-40
PMID: 9461007
-
A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.
Clin Exp Metastasis. 2004;21(2):119-28
PMID: 15168729
-
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
J Clin Invest. 2004 Dec;114(12):1714-25
PMID: 15599396
-
Adherence to osteopontin via alphavbeta3 suppresses phorbol ester-mediated apoptosis in MCF-7 breast cancer cells that overexpress protein kinase C-alpha.
Int J Oncol. 2000 Dec;17(6):1237-43
PMID: 11078811
-
Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.
Clin Exp Metastasis. 2002;19(5):427-36
PMID: 12198771
-
Integrin alpha V beta 3 expression by bone-residing breast cancer metastases.
Diagn Mol Pathol. 1996 Jun;5(2):127-35
PMID: 8727100
-
Alphav integrins mediate adhesion and migration of breast carcinoma cell lines.
Clin Exp Metastasis. 1998 Jan;16(1):50-61
PMID: 9502077
-
Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain.
J Biol Chem. 2000 Dec 22;275(51):39867-73
PMID: 10964931
-
A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells.
Nucleic Acids Res. 1990 Feb 25;18(4):1068
PMID: 2156225
-
MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.
Clin Exp Metastasis. 2000;18(7):553-60
PMID: 11688960
-
Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
Cancer Res. 1993 Mar 15;53(6):1421-30
PMID: 7680285
-
The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration.
J Cell Sci. 1998 Feb;111 ( Pt 4):469-78
PMID: 9443896
-
Requirement of vascular integrin alpha v beta 3 for angiogenesis.
Science. 1994 Apr 22;264(5158):569-71
PMID: 7512751
-
Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: effects of alphavbeta3 and alphaIIbbeta3 antagonists.
Clin Exp Metastasis. 2004;21(6):553-61
PMID: 15679053
-
Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors.
J Mammary Gland Biol Neoplasia. 1998 Apr;3(2):191-200
PMID: 10819527
-
Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9482-7
PMID: 12874388
-
Inhibitors of integrins.
Curr Opin Pharmacol. 2002 Aug;2(4):394-402
PMID: 12127872
-
Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression.
Breast Cancer Res Treat. 2000 Jun;61(3):249-60
PMID: 10966001
-
Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast.
Br J Cancer. 1997;75(2):221-9
PMID: 9010030
-
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo.
Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):119-24
PMID: 11134507
-
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 2001 Mar 1;410(6824):50-6
PMID: 11242036
-
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.
Cancer Res. 1992 Mar 15;52(6):1399-405
PMID: 1540948
-
Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth.
Cancer Res. 2004 Feb 1;64(3):977-84
PMID: 14871828
-
Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
Cancer Res. 1999 Jan 1;59(1):241-8
PMID: 9892213
-
The clinical course of bone metastases from breast cancer.
Br J Cancer. 1987 Jan;55(1):61-6
PMID: 3814476
-
Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme.
Cancer Res. 2004 Apr 15;64(8):2751-8
PMID: 15087390
-
Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF.
EMBO J. 1997 Sep 15;16(18):5600-7
PMID: 9312019
-
Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors.
Hum Pathol. 1992 Oct;23(10):1159-66
PMID: 1383121
-
Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247.
Clin Exp Metastasis. 2004;21(2):129-38
PMID: 15168730